UNC Metastatic Cancer Radiation Therapy Registry
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Radiation therapy.
- Who it may be relevant to
- Registry conditions: Cancer, Metastatic Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.
Interventions
- Radiation Radiation therapy
Subjects with metastatic cancer receive radiation therapy.
Primary outcome measures
- Clinical Data [Time frame: Up to 1 month]
Secondary outcome measures (1)
- Patient reported outcomes (PRO) [Time frame: Baseline, 1 month, 3 months, 6 months, 9 months, and 12 months]
Eligibility criteria
Inclusion criteria
Written informed consent was obtained to participate in the study and HIPAA
Authorization for release of personal health information. Ability to understand and willingness to sign informed consent
Diagnosed with or is suspected to have metastatic cancer.
Age ≥ 18 years at the time of consent.
Evaluated to receive radiation therapy as part of their standard-of-care treatment plan.
Exclusion criteria
All participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study:
Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill — Chapel Hill
Identifiers
NCT: NCT06306924 · LCCC2303